Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer …

FH Schröder, J Hugosson, S Carlsson, T Tammela… - European urology, 2012 - Elsevier
BACKGROUND: Metastatic disease is a major morbidity of prostate cancer (PCa). Its
prevention is an important goal. OBJECTIVE: To assess the effect of screening for PCa on …
被引用次数：354 相关文章

Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer …

FH Schröder, J Hugosson, S Carlsson… - European …, 2012 - europepmc.org
Screening for prostate cancer decreases the risk of developing metastatic disease: findings
from the European Randomized Study of Screening for Prostate Cancer (ERSPC). - Abstract …

Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate …

FH Schröder, J Hugosson, S Carlsson, T Tammela… - European Urology, 2012 - infona.pl
Metastatic disease is a major morbidity of prostate cancer (PCa). Its prevention is an
important goal. To assess the effect of screening for PCa on the incidence of metastatic …
[PDF] academia.edu

[PDF][PDF] Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate …

FH Schroder, J Hugosson, S Carlsson, T Tammela… - 2012 - academia.edu
Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease:
Findings from the European Randomized Study o Page 1 Platinum Priority – Prostate Cancer …

Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer …

F Schröder, J Hugosson, S Carlsson… - … : Official Journal of the …, 2012 - repub.eur.nl
Background: Metastatic disease is a major morbidity of prostate cancer (PCa). Its prevention
is an important goal. Objective: To assess the effect of screening for PCa on the incidence of …

[引用][C] Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate …

FH SCHRÖDER, J HUGOSSON… - European …, 2012 - pascal-francis.inist.fr
Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings
from the European Randomized Study of Screening for Prostate Cancer (ERSPC) CNRS Inist …

Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer …

FH Schröder, J Hugosson, S Carlsson, T Tammela… - 2012 - pubmed.ncbi.nlm.nih.gov
Background Metastatic disease is a major morbidity of prostate cancer (PCa). Its prevention
is an important goal. Objective To assess the effect of screening for PCa on the incidence of …

Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer …

FH Schröder, J Hugosson, S Carlsson… - European …, 2012 - researchportal.tuni.fi
Abstract< p> Background: Metastatic disease is a major morbidity of prostate cancer (PCa).
Its prevention is an important goal. Objective: To assess the effect of screening for PCa on …

Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate …

FH Schröder, J Hugosson, S Carlsson, T Tammela… - European Urology, 2012 - infona.pl
Metastatic disease is a major morbidity of prostate cancer (PCa). Its prevention is an
important goal. To assess the effect of screening for PCa on the incidence of metastatic …

[引用][C] Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate …

FH SCHRÖDER, J HUGOSSON, S CARLSSON… - European urology, 2012 - Elsevier